FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for treating breast cancer at early stages of tumor process. That is followed by intra-tumor introduction of radiopharmaceutical 99 mTc-technefite in dose of 7.5 to 15 MBq. After 60–120 minutes, the axillary, parasternal, supra- and subclavian lymph nodes are scintigraphically examined on the side of the breast tumor localization. A signal lymph node which accumulates a radiopharmaceutical is detected, then it is removed and an urgent histologic examination is performed. If there is no metastases in the signal lymph node, the breast tissue sector is excised together with the tumor, and if observing the tumor changes in the signaling lymph node, the breast tissue sector is excised together with the tumor and lymphadenectomy.
EFFECT: method provides surgical treatment of breast cancer at early stages of tumor process with individualization of lymphadenectomy volume, as well as minimization of irradiation of patient and reduced time of operation due to intraoperative examination of signaling lymph node.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SIGNAL LYMPH NODE BIOPSY IN PATIENTS WITH BREAST CANCER | 2014 |
|
RU2549488C1 |
METHOD FOR DETECTION OF SIGNAL LYMPHATIC NODES IN BREAST CANCER PATIENTS BY COLLOIDAL RADIOPHARMACEUTICALS WITH VARIOUS PARTICLE DIAMETRES | 2011 |
|
RU2469334C1 |
DIAGNOSTIC TECHNIQUE FOR REGIONAL LYMPH NODE INVOLVEMENT IN PATIENTS SUFFERING PROSTATE CANCER | 2014 |
|
RU2564965C1 |
METHOD OF INDIVIDUAL PRE-RADIATION PREPARATION OF PATIENTS SUFFERING FROM BREAST CANCER | 2008 |
|
RU2377020C1 |
METHOD FOR TARGETED BRACHYTHERAPY OF PROSTATE CANCER UNDER HYBRID PSMA-RECEPTOR SCINTIGRAPHY NAVIGATION | 2022 |
|
RU2788859C2 |
METHOD OF DETERMINING INDIVIDUAL TOPOGRAPHY OF RADIATION FIELDS IN PATIENTS WITH BREAST CANCER | 2009 |
|
RU2394599C1 |
METHOD OF TREATING ORAL CANCER | 2019 |
|
RU2713530C2 |
METHOD FOR OPTIMIZING LYMPH NODE DISSECTION IN PRIMARY RESECTABLE BREAST CANCER | 2017 |
|
RU2691568C1 |
METHOD OF TREATING INITIAL STAGES OF ORAL CANCER | 2019 |
|
RU2713940C1 |
METHOD FOR DETERMINING INDICATIONS FOR LYMPHODISSECTION IN PATIENTS WITH VULVAR CANCER | 2018 |
|
RU2723993C2 |
Authors
Dates
2019-09-02—Published
2018-11-29—Filed